Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2011

Open Access 01-12-2011 | Research article

Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency

Authors: Kirsten I Marchand, Eugenia Oviedo-Joekes, Daphne Guh, Suzanne Brissette, David C Marsh, Martin T Schechter

Published in: BMC Health Services Research | Issue 1/2011

Login to get access

Abstract

Background

Substitution with opioid-agonists (e.g., methadone) has shown to be an effective treatment for chronic long-term opioid dependency. Patient satisfaction with treatment has been associated with improved addiction treatment outcomes. However, there is a paucity of studies evaluating patients' satisfaction with Opioid Substitution Treatment (OST). In the present study, participants' satisfaction with OST was evaluated at 3 and 12 months. We sought to test the relationship between satisfaction and patients' characteristics, the treatment modality received and treatment outcomes.

Methods

Data from a randomized controlled trial, the North American Opiate Medication Initiative (NAOMI), conducted in Vancouver and Montreal (Canada) between 2005-2008, was analyzed. The NAOMI study compared the effectiveness of oral methadone vs. injectable diacetylmorphine over 12 months. A small sub-group of patients received injectable hydromorphone on a double blind basis with diacetylmorphine. The Client Satisfaction Questionnaire (CSQ-8) was used to measure satisfaction with treatment. CSQ-8 scores, as well as retention and response to treatment, did not differ between those receiving hydromorphone and diacetylmorphine at 3 or 12 months assessments; therefore, these two groups were analyzed together as the 'injectable' treatment group.

Results

A total of 232 (92%) and 237 (94%) participants completed the CSQ-8 at 3 and 12 months, respectively. Participants in both groups were highly satisfied with treatment. Independent of treatment group, participants satisfied with treatment at 3 months were more likely to be retained at 12 months. Multivariate analysis indicated that satisfaction was greater among those randomized to the injection group after controlling for treatment effectiveness. Participants who were retained, responded to treatment, and had fewer psychological symptoms were more satisfied with treatment. Finally, open-ended comments were made by 149 (60.3%) participants; concerns about the randomization process and the study ending were most commonly reported by participants receiving the oral and injectable medications, respectively.

Conclusions

The higher satisfaction among those receiving medically prescribed injectable diacetylmorphine (or hydromorphone) supports current evidence regarding the attractiveness of this treatment for long-term, opioid-dependent individuals not benefiting sufficiently from other treatments. In addition, the measurement of treatment satisfaction provides valuable information about participants at risk of relapse and in need of additional services.

Trial Registration

ClinicalTrials.gov Identifier: NCT00175357
Literature
1.
Kuyper LM, Hogg RS, Montaner JSG, Schechter MT, Wood E: The Cost of Inaction on Hiv Transmission Among Injection Drug Users and the Potential for Effective Interventions. J Urban Health. 2004, 81: 655-660.CrossRefPubMedPubMedCentral
2.
Gowing L, Farrell M, Bornemann R, Sullivan L, Ali R: Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2008, CD004145.
3.
Ward J, Hall W, Mattick RP: Role of maintenance treatment in opioid dependence. Lancet. 1999, 353: 221-6. 10.1016/S0140-6736(98)05356-2.CrossRefPubMed
4.
Van den Brink W, Haasen C: Evidenced-based treatment of opioid-dependent patients. Can J Psychiatry. 2006, 51: 635-46.PubMed
5.
McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP: The effects of psychosocial services in substance abuse treatment. JAMA. 1993, 269: 1953-9. 10.1001/jama.269.15.1953.CrossRefPubMed
6.
Amato L, Davoli M, A Perucci C, Ferri M, Faggiano F, P Mattick R: An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat. 2005, 28: 321-9. 10.1016/j.jsat.2005.02.007.CrossRefPubMed
7.
Mattick RP, Breen C, Kimber J, Davoli M: Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009, CD002209.
8.
Zhang Z, Friedmann PD, Gerstein DR: Does retention matter? Treatment duration and improvement in drug use. Addiction. 2003, 98: 673-84. 10.1046/j.1360-0443.2003.00354.x.CrossRefPubMed
9.
Health Canada: Best practices in methadone maintenance treatment. 2002, Ontario, Canada.: Minister of Public Works and Government Services Canada
10.
The College of Physicians of Ontario: Methadone maintenance guidelines. 2005
11.
Bukstein OG: Satisfaction with treatment for attention-deficit/hyperactivity disorder. Am J Manag Care. 2004, 10: S107-16.PubMed
12.
Saila T, Mattila E, Kaila M, Aalto P, Kaunonen M: Measuring patient assessments of the quality of outpatient care: a systematic review. J Eval Clin Pract. 2008, 14: 148-54. 10.1111/j.1365-2753.2007.00824.x.CrossRefPubMed
13.
Lehman AF, Zastowny TR: Patient satisfaction with mental health services: a meta-analysis to establish norms. Eval Program Plann. 1983, 6: 265-74. 10.1016/0149-7189(83)90006-X.CrossRefPubMed
14.
Batchelor C, Owens DJ, Read M, Bloor M: Patient satisfaction studies: methodology, management and consumer evaluation. Int J Health Care Qual Assur. 1994, 7: 22-30. 10.1108/09526869410074720.CrossRefPubMed
15.
Revicki DA: Patient assessment of treatment satisfaction: methods and practical issues. Gut. 2004, 53 (Suppl 4): 40-4. iv
16.
Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M: Issues in the measurement of satisfaction with treatment. Am J Manag Care. 1997, 3: 579-94.PubMed
17.
Madden A, Lea T, Bath N, Winstock AR: Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment. Drug Alcohol Rev. 2008, 27: 671-8. 10.1080/09595230801935706.CrossRefPubMed
18.
Perez de los Cobos J, Fidel G, Escuder G, Haro G, Sanchez N, Pascual C, Valderrama JC, Valero S, Trujols J: A satisfaction survey of opioid-dependent clients at methadone treatment centres in Spain. Drug Alcohol Depend. 2004, 73: 307-13. 10.1016/j.drugalcdep.2003.11.001.CrossRefPubMed
19.
Perez de Los Cobos J, Trujols J, Valderrama JC, Valero S, Puig T: Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment. Drug Alcohol Depend. 2005, 79: 405-12. 10.1016/j.drugalcdep.2005.03.021.CrossRefPubMed
20.
Sell L, Zador D: Patients prescribed injectable heroin or methadone -their opinions and experiences of treatment. Addiction. 2004, 99: 442-9. 10.1111/j.1360-0443.2003.00668.x.CrossRefPubMed
21.
King VL, Stoller KB, Hayes M, Umbricht A, Currens M, Kidorf MS, Carter JA, Schwartz R, Brooner RK: A multicenter randomized evaluation of methadone medical maintenance. Drug Alcohol Depend. 2002, 65: 137-48. 10.1016/S0376-8716(01)00155-7.CrossRefPubMed
22.
King VL, Kidorf MS, Stoller KB, Schwartz R, Kolodner K, Brooner RK: A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model. J Subst Abuse Treat. 2006, 31: 385-93. 10.1016/j.jsat.2006.05.014.CrossRefPubMed
23.
Kumar RM, Rajwal M: Survey of client satisfaction with methadone maintenance programmes [abstract]. Psychiatric Bulletin. 2006, 16-18.
24.
Corrigan PW: Consumer satisfaction with institutional and community care. Community Ment Health J. 1990, 26: 151-65. 10.1007/BF00752392.CrossRefPubMed
25.
Morris ZS, Gannon M: Drug misuse treatment services in Scotland: predicting outcomes. Int J Qual Health Care. 2008, 20: 271-6. 10.1093/intqhc/mzn019.CrossRefPubMed
26.
Kelly SM, O'Grady KE, Brown BS, Mitchell SG, Schwartz RP: The Role of Patient Satisfaction in Methadone Treatment. American Journal of Drug & Alcohol Abuse. 2010, 36: 150-154. 10.3109/00952991003736371.CrossRef
27.
Zhiwei Zhang , Gerstein DR, Friedmann PD: Patient Satisfaction and Sustained Outcomes of Drug Abuse Treatment. Journal of Health Psychology. 2008, 13: 388-400. 10.1177/1359105307088142.CrossRefPubMedPubMedCentral
28.
McLellan AT, Hunkeler E: Patient satisfaction and outcomes in alcohol and drug abuse treatment. Psychiatr Serv. 1998, 49: 573-5.CrossRefPubMed
29.
Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT: Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med. 2009, 361: 777-86. 10.1056/NEJMoa0810635.CrossRefPubMed
30.
Oviedo-Joekes E, Nosyk B, Marsh D, Guh D, Brissette S, Gartry C, Krausz M, Anis A, Schechter MT: Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: Rationale and design of the NAOMI Study. Clinical Trials. 2009, 261-271.
31.
Oviedo-Joekes E, Nosyk B, Brissette S, Chettiar J, Schneeberger P, Marsh DC, Krausz M, Anis A, Schechter MT: The North American Opiate Medication Initiative (NAOMI): Profile of Participants in North America's First Trial of Heroin-Assisted Treatment. J Urban Health. 2008, 85: 812-25. 10.1007/s11524-008-9312-9.CrossRefPubMedPubMedCentral
32.
Oviedo-Joekes E, Marsh D, Guh D, Brissette S, Schechter MT: Potency ratio of hydromorphone and diacetylmorphine in substitution treatment for long-term opioid dependency. J Opioid Manag.
33.
Oviedo-Joekes E, Guh D, Brissette S, Marchand K, Marsh D, Chettiar J, Nosyk B, Krausz M, Anis A, Schechter MT: Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women. Drug Alcohol Depend. 2010
34.
Kokkevi A, Hartgers C: EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res. 95: 208-210.
35.
Marsden J, Gossop M, Stewart D, Best D, Farrell M, Lehmann P, Edwards C, Strang J: The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction. 1998, 93: 1857-67. 10.1046/j.1360-0443.1998.9312185711.x.CrossRefPubMed
36.
Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD: Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979, 2: 197-207. 10.1016/0149-7189(79)90094-6.CrossRefPubMed
37.
Nguyen TD, Attkisson CC, Stegner BL: Assessment of patient satisfaction: development and refinement of a service evaluation questionnaire. Eval Program Plann. 1983, 6: 299-313. 10.1016/0149-7189(83)90010-1.CrossRefPubMed
38.
Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR: Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004, 2: 12-10.1186/1477-7525-2-12.CrossRefPubMedPubMedCentral
39.
O'Regan C, Ryan M: Patient satisfaction with an emergency department psychiatric service. I Int J Health Care Qual Assur. 2009, 22: 525-34. 10.1108/09526860910975616.CrossRefPubMed
40.
De Wilde EF, Hendriks VM: The Client Satisfaction Questionnaire: psychometric properties in a Dutch addict population. Eur Addict Res. 2005, 11: 157-62. 10.1159/000086396.CrossRefPubMed
41.
Villafranca SW, McKellar JD, Trafton JA, Humphreys K: Predictors of retention in methadone programs: a signal detection analysis. Drug Alcohol Depend. 2006, 83: 218-24. 10.1016/j.drugalcdep.2005.11.020.CrossRefPubMed
42.
Ilgen MA, Trafton JA, Humphreys K: Response to methadone maintenance treatment of opiate dependent patients with and without significant pain. Drug Alcohol Depend. 2006, 82: 187-193. 10.1016/j.drugalcdep.2005.09.005.CrossRefPubMed
43.
Trafton JA, Tracy SW, Oliva EM, Humphreys K: Different Components of Opioid-Substitution Treatment Predict Outcomes of Patients With and Without a Parent With Substance-Use Problems. J Stud Alcohol Drugs. 2007, 68: 165-172.CrossRefPubMed
44.
Ward J: Part C. The case of community methadone treatment programs. World Health Organization (WHO), Evaluation of Psychoactive Substance Use Disorder Treatment: Workbook 6 Client Satisfaction Evaluations. 2000, Geneva: World Health Organization, 32-38.
45.
Greenley JR, Schoenherr RA: Organization effects on client satisfaction with humaneness of service. J Health Soc Behav. 1981, 22: 2-18. 10.2307/2136364.CrossRefPubMed
46.
Hser YI, Evans E, Huang D, Anglin DM: Relationship between drug treatment services, retention, and outcomes. Psychiatr Serv. 2004, 55: 767-74. 10.1176/appi.ps.55.7.767.CrossRefPubMed
47.
Ruggeri M, Dall'Agnola R, Agostini C, Bisoffi G: Acceptability, sensitivity and content validity of the VECS and VSSS in measuring expectations and satisfaction in psychiatric patients and their relatives. Soc Psychiatry Psychiatr Epidemiol. 1994, 29: 265-76. 10.1007/BF00802049.CrossRefPubMed
48.
Hser YI, Huang D, Chou CP, Anglin MD: Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up study. Eval Rev. 2007, 31: 548-63. 10.1177/0193841X07307315.CrossRefPubMed
49.
Bjorngaard JH, Rustad AB, Kjelsberg E: The prisoner as patient - a health services satisfaction survey. BMC Health Serv Res. 2009, 9: 176-10.1186/1472-6963-9-176.CrossRefPubMedPubMedCentral
50.
Soergaard KW, Nivison M, Hansen V, Oeiesvold T: Treatment needs and acknowledgement of illness - importance for satisfaction with psychiatric inpatient treatment. BMC Health Serv Res. 2008, 8: 103-10.1186/1472-6963-8-103.CrossRefPubMedPubMedCentral
51.
Aharony L, Strasser S: Patient satisfaction: what we know about and what we still need to explore. Med Care Rev. 1993, 50: 49-79. 10.1177/002570879305000104.CrossRefPubMed
52.
Oviedo-Joekes E, Guh D, Marsh DC, Brissette S, Nosyk B, Krausz M, Anis A, Christian WM, Spittal P, Schechter MT: Characteristics and response to treatment among Aboriginal people receiving heroin-assisted treatment. Can J Public Health. 2010, 101: 210-2.PubMed
53.
Callon C, Wood E, Marsh D, Li K, Montaner J, Kerr T: Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver. J Opioid Manag. 2006, 2: 35-41.PubMed
54.
Canadian Aboriginal AIDS Network: Joining the Circle, Phase II. 2004
55.
Donovan DM, Kadden RM, DiClemente CC, Carroll KM: Client satisfaction with three therapies in the treatment of alcohol dependence: results from project MATCH. Am J Addict. 2002, 11: 291-307. 10.1080/10550490290088090.CrossRefPubMed
56.
Carlson MJ, Gabriel RM: Patient satisfaction, use of services, and one-year outcomes in publicly funded substance abuse treatment. Psychiatr Serv. 2001, 52: 1230-6. 10.1176/appi.ps.52.9.1230.CrossRefPubMed
57.
Thomson CL, Morley KC, Teesson M, Sannibale C, Haber PS: Issues with recruitment to randomised controlled trials in the drug and alcohol field: a literature review and Australian case study. Drug Alcohol Rev. 2008, 27: 115-22. 10.1080/09595230701829561.CrossRefPubMed
58.
Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R: Barriers to Participation in Randomised Controlled Trials: A Systematic Review. J Clin Epidemiol. 1999, 52: 1143-1156. 10.1016/S0895-4356(99)00141-9.CrossRefPubMed
59.
McCarthy-Keith D, Nurudeen S, Armstrong A, Levens E, Nieman LK: Recruitment and retention of women for clinical leiomyoma trials. Contemp Clin Trials. 2010, 31: 44-8. 10.1016/j.cct.2009.09.007.CrossRefPubMed
Metadata
Title
Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency
Authors
Kirsten I Marchand
Eugenia Oviedo-Joekes
Daphne Guh
Suzanne Brissette
David C Marsh
Martin T Schechter
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2011
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-11-174

Other articles of this Issue 1/2011

BMC Health Services Research 1/2011 Go to the issue

Research article

Performance measures of the specialty referral process: a systematic review of the literature

Research article

A web-based appointment system to reduce waiting for outpatients: A retrospective study

Research article

Under-utilization of health care services for infectious diseases syndromes in rural Azerbaijan: A cross-sectional study

Research article

Assessing the contribution of prescribing in primary care by nurses and professionals allied to medicine: a systematic review of literature

Research article

A multi-region assessment of population rates of cardiac catheterization and yield of high-risk coronary artery disease

Research article

Conceptual models for Mental Distress among HIV-infected and uninfected individuals: A contribution to clinical practice and research in primary-health-care centers in Zambia